Mackenzie Financial
SLGC

Mackenzie Financial’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Mackenzie Financial’s Portfolio SLGC Stock Details SLGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,200
Closed -$25.8K – 1634
2023
Q4 		$25.8K Hold
10,200
– – ﹤0.01% 1477
2023
Q3 		$23.5K Hold
10,200
– – ﹤0.01% 1449
2023
Q2 		$23.1K Hold
10,200
– – ﹤0.01% 1493
2023
Q1 		$26K Hold
10,200
– – ﹤0.01% 1475
2022
Q4 		$25.6K Hold
10,200
– – ﹤0.01% 1389
2022
Q3 		$30K Hold
10,200
– – ﹤0.01% 1394
2022
Q2 		$46K Buy
+10,200
New +$60.7K ﹤0.01% 1403

Mackenzie Financial's SLGC Position: Q1 2024 in Review

Mackenzie Financial sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 10,200 shares — an estimated $25.8K sold.

Mackenzie Financial first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $46K in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Mackenzie Financial reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Mackenzie Financial sold 10,200 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $25.8K.
  • Mackenzie Financial first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
  • Mackenzie Financial's SomaLogic, Inc. Class A Common Stock position peaked at $46K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Mackenzie Financial's 13F filing for Q1 2024, filed 10 May 2024.